Posters

Machine learning and natural language processing to power literature search for timely, meaningful results

November 15, 2018

AUTHORS: Wagner W., Kuiper J., Feinman T., Shalev E., Whittington C, Aguila M.d. CONFERENCE: ISPOR Europe  DATE: November 10-14, 2018. Objective: We illustrate the use of DOC Search with a real example of a situation when relevant information was needed for a presentation regarding analytic considerations in oncology trials applicable to regulatory and market access […]

Comparing Patient Profiles of Clopidogrel Versus Ticagrelor: A Systematic Literature Review and Meta-Analysis

November 13, 2018

AUTHORS: Cuisset T., Aponte Z.,  Paek D., Aguila Md, Girotra S., Sibbing D. CONFERENCE: AHA DATE: November 10-12, 2018. Objective: To conduct a systematic literature review and meta-analysis to summarize the differences in patient profiles for clopidogrel versus ticagrelor in real world populations with ACS. See poster 2018-AHA-DRE-Sanofi-Poster

Nurse-delivered digital-health interventions: A systematic review and meta-analysis

November 10, 2018

AUTHORS: Rice F, Coumel S, Monteil C., Murray E, Lewis S. Z., Egbuonu-Davis L. CONFERENCE: Diabetes Technology Meeting (DTS)  DATE: November 8-9, 2018. Objective: To examine nurse delivered digital health educational or self-management interventions to improve clinical and behavioral outcomes in DM. See poster 2018-DTS-DRE-Sanofi-Poster

Global Impact of Nurse Interventions on Diabetic Treatment Regimens

September 30, 2018

AUTHORS: Rice D., Coumel S., Monteil C., Murray E, Lewis S. Z., Egbuonu-Davis L.  CONFERENCE: Foundation of European Nurses in Diabetes (FEND) DATE: September 28-29, 2018. Objective: This review aimed to better understand the safety and efficacy of FRCs of GLP-1 RAs and basal insulin (BI) in comparison with BI, GLP-1 RA, basal-bolus insulin, premix insulin, and free […]

Quick and Easy Technology to Assist With Scoping Reviews and PICO Refinement

September 15, 2018

AUTHORS: Patel S., Lewis S. Z., Whittington C., Feinman T. CONFERENCE: G-I-N DATE: September 12-14, 2018. Objective: The purpose of this project was to perform a rapid assessment of the literature using DOC Search to inform the refinement and finalization of PICO questions for a guideline update. See poster 2018-G-I-N-DRE-Poster

Do “Nurse Interventions” Positively Impact both Behavioral and Clinical Outcomes in Patients with Diabetes?

August 21, 2018

AUTHORS: Rice D., Coumel S., Monteil C., Murray E., Lewis S.Z., Egbuonu-Davis L. CONFERENCE: American Association of Diabetes Educators -AADE DATE: August 17-20, 2018. Objective(s): To examine applications and interventions used by nurses to improve clinical and behavioral outcomes in diabetes. Hypothesis: interventions such as diabetes education delivered by nurses and diabetes educators improve patient outcomes. 2018-AADE-DRE-Sanofi-Endo-046-Poster See poster

The Importance of Patient Satisfaction with Insulin Device Administration: Does a Positive Experience Drive Improved Diabetes Self-Management and Adherence?

August 21, 2018

AUTHORS: Rice D., Liska J., Beaudin M, Del Aguila M., Murray E., Beal A. CONFERENCE: American Association of Diabetes Educators -AADE DATE: August 17-20, 2018 Objective(s): • To compare the patient experience with self-injecting pens and insulin pumps and explore how satisfaction with those devices affects insulin adherence, diabetes self-management and patient health outcomes. 2018-AADE-DRE-Sanofi-Endo-031-Poster See poster

Promoters and Barriers of Engagement in Type 2 Diabetes Mellitus Populations with Real World Technological Interventions

June 27, 2018

AUTHORS: Duvall K., Trasy A., Murray E., Milam R, Sayre T, Beal A. CONFERENCE: ADA 2018 DATE: June 22-26, 2018. Objective(s): This review aims to evaluate real-world studies that discuss engagement elements of telemedicine/mobile health or web-based technological interventions focusing on T2DM. 2018-ADA-DRE-Sanofi-Poster See poster detail

Comparative Efficacy Of Consolidation Therapy After Chemoradiation Therapy (Crt) In Patients With Unresectable, Stage Iii Non-Small Cell Lung Cancer (Nsclc): A Network Meta-Analysis

May 24, 2018

AUTHORS: Husain F., Harari O., Fazeli M., Zhang Y. CONFERENCE: ISPOR 2018 DATE: May 19-23, 2018. Objectives: This study aims to estimate the comparative clinical efficacy of consolidation therapies after cCRT, by using network meta-analysis (NMA). This current analysis focuses on progression free survival (PFS). See poster 2018-ISPOR-AstraZeneca-Poster

Influenza Vaccination In Diabetes Mellitus: Exploring Patient Burden And Strategies To Increase Uptake

May 23, 2018

AUTHORS: Liska J., Banyon O., Samson S., Whittington C., Murray E., Beal A. CONFERENCE: ISPOR 2018 DATE: May 19-23, 2018. Objective(s): Explore the benefits of influenza vaccination in the diabetes population and determine characteristics of successful vaccination programs in diabetes and other high-risk populations. Vaccination strategies in higher uptake populations, such as healthcare workers (where vaccination may be mandatory) and […]

Benefits and Risks of Clopidogrel Versus Aspirin Monotherapy for Acute Ischemic Stroke: A Systematic Review and Meta-analysis

April 13, 2018

AUTHORS: Shalini G., Min L., Bo H., Liping L., Dara P., Toby S. CONFERENCE: ESC 2018 DATE: April 11-13, 2018. Objective(s): To conduct a systematic literature review to compare the efficacy and safety of clopidogrel versus aspirin monotherapy in patients with acute ischemic stroke.   See poster 2018-ESC-DRE-Sanofi-Poster

Clinical Outcomes Associated with De-Escalation from Ticagrelor to Clopidogrel in Patients with Acute Coronary Syndrome

March 13, 2018

AUTHORS: Angiolillo D, Paek D, Shah R, Fazeli MS, Girotra S CONFERENCE: ACC 2018 DATE: March 10-12, 2018. Objective(s): To conduct a systematic literature review to assess the rate of efficacy and safety outcomes following a switch from ticagrelor to clopidogrel therapy in patients with acute coronary syndrome. 2018-ACC-DRE-Sanofi-UF-Poster See poster

Prevalence and Timing of De-Escalation Therapy from Ticagrelor to Clopidogrel in Acute Coronary Syndrome Patients: Results of a Meta-Analysis

March 13, 2018

AUTHORS: Angiolillo D, Paek D, Shah R, Sayre T, Clausel A, Girotra S CONFERENCE: ADA 2018 DATE: March 10-12, 2018. Aim: To conduct a systematic literature review to assess the prevalence rate of de-escalation from ticagrelor to clopidogrel in patients with ACS and to assess the time at which de-escalation takes place following the index event. 2018-ACC-DRE-Sanofi-UF-Poster […]

Transparency Matters: Use of Digital Software Platform in Replicating Published Systematic Literature Reviews and Network Meta-Analyses.

December 9, 2017

AUTHORS: Husain, F., Kuang, Y., Feinman, T., Whittington, C., Sayre, T., del Aguila, M. CONFERENCE: ISPOR 2017 DATE: November 4-8, 2017 Objective(s): This work assessed the transparency and replicability of manual methods with comparison to software-assisted replication for search and analysis of published systematic literature reviews (SLRs) and network meta-analyses (NMAs). See poster 2017-ISPOR-DRE-Poster

Network meta-analysis of iGlarLixi, a fixed-ratio combination GLP-1 RA and basal insulin, versus insulin premix

December 9, 2017

AUTHORS: Sayre T., Shah R., Thomas J., Murray E., Brulle-Wohlhueter C., Shaunik A., Perfetti R. CONFERENCE: IDF Congress 2017 DATE: December 4-8, 2017. Aim: To better understand the clinical efficacy of iGlarLixi compared with insulin intensification options, especially premix insulins, in patients with T2D inadequately controlled on BI See poster

Network meta-analysis of treatments for type 2 diabetes in patients inadequately controlled on oral antidiabetics

December 9, 2017

AUTHORS: Shah R., Sayre T., Thomas J., Murray E., Brulle-Wohlhueter C., Shaunik A. CONFERENCE: IDF Congress 2017 DATE: December 4-8, 2017. Aim: To better understand the treatment efficacy and safety of fixed-ratio combinations (FRCs) of BI and GLP- 1 RA compared with BI, GLP- 1 RA or OAD monotherapy using network meta-analysis in the absence of head-to-head randomized controlled trials (RCT) See […]

Efficacy and safety of fixed-ratio combination of GLP-1 RA plus BI in type 2 diabetes mellitus: a network meta-analysis

December 9, 2017

AUTHORS: Shah R., Sayre T., Thomas J., Murray E., Brulle-Wohlhueter C., Shaunik A. CONFERENCE: IDF Congress 2017 DATE: December 4-8, 2017. Aim: This review aimed to better understand the safety and efficacy of FRCs of GLP-1 RAs and basal insulin (BI) in comparison with BI, GLP-1 RA, basal-bolus insulin, premix insulin, and free combination GLP-1 RA and BI via […]

Innovative AI-powered technologies to facilitate evidence dissemination to inform medical and healthcare decisions

December 7, 2017

AUTHORS: Lewis S.Z., Feinman F., del Aguila M., Newton M., Battista R.J., Shalev E., Kuiper J. CONFERENCE: 10th Annual Conference on the Science of Dissemination and Implementation in Health DATE: December 4-6, 2017. 2017-DRE-Academy-Health-Poster See poster

Impact of Patient Device Experience on Acceptance and Adherence in Diabetes Mellitus

December 3, 2017

AUTHORS: Liska J., Beaudin M., Rice D., del Aguila M., Murray E., Beal A. CONFERENCE: European Society for Patient Adeherence, Compliance and Persistence- ESPACOMP 2017 DATE: December 4-8, 2017. Aim: To conduct a systematic literature review to examine how the patient experience with self-injectable insulin pen devices for diabetes mellitus impacts treatment acceptance and adherence, […]

Predictors of Flu Vaccine Uptake in Patients with Diabetes Mellitus

December 2, 2017

AUTHORS: Liska J., Banyon O., Samson S., Sayre T., Shah R., Beal A. CONFERENCE: European Society for Patient Adeherence, Compliance and Persistence- ESPACOMP 2017 DATE: November 30- December 2, 2017. Aim: To conduct a systematic literature review to examine how the patient experience with self-injectable insulin pen devices for diabetes mellitus impacts treatment acceptance and adherence, […]

Real-World Incidence of Malignancies, Infections and Auto-Immune Diseases in Persons with Rheumatoid Arthritis Treated with Biological vs. Non-Biological Disease-Modifying Antirheumatic Drugs: A systematic Review and Meta-Analysis

August 31, 2017

AUTHORS: Simon T., Kostelec J., Franek J. CONFERENCE: 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management ICPE 2017 DATE: August 26-30, 2017. Objective(s): To perform a systematic literature review to identify publications reporting the rate of malignancies, autoimmune diseases, and infections for BDMARDs vs. NBDMARDs To determine the comparative incidence of immune-related events through meta-analysis See poster […]

Term Indexing Technology to Support the Feasibility Assessment of a Benefit-Risk Network Meta-Analysis.

June 23, 2017

AUTHORS: Snyder S., Bhattacharya M., Hendrickson B, Butylkova K, Lievano F; Scarzzini L, CONFERENCE: DIA Annual Meeting 2017 DATE: June 18-22, 2017. Objective: Perform a BRA of interventions across two therapeutic classes using a NMA approach Use term-indexing technology to improve synonym management, feasibility assessment, and outcome selection for NMA 2017-DIA-DRE-Abbvie-NMA-Poster See poster

Digital Approaches to Analyzing Evidence in Support of Personalized Oncology Guidelines.

September 30, 2016

AUTHORS: Diekemper R., MPH, Lewis S. Z. CONFERENCE: G-I-N 2016 DATE: September 2016. Objective: To demonstrate how a targeted systematic review including subgroup analyses can be used to inform personalized clinical practice guidelines by evaluating the efficacy of immunotherapy drugs for treating melanoma patients. See poster

Terminology Management in Guideline Development: Early Versus Late Binding of Synonyms.

September 30, 2016

AUTHORS: Whittington C, Zelman S.L, Byers S., Clausel A., Crumrine A., Franek J., Murray E., Sayre T., Battista R. CONFERENCE: G-I-N 2016 DATE: September 2016. See poster 2016-DRE-GIN-Poster

IBM Watson Mega Analytical Database Supports Healthcare Solutions

December 16, 2015

AUTHORS: Lewis S. Z.; Battista R. CONFERENCE: 8th Annual Conference on the Science of Dissemination and Implementation in Health DATE: December 14-15, 2015. Doctor Evidence (DRE), an evidence-based SaaS company, is contributing 2 million additional data points from peer-reviewed articles, clinical research studies, conference proceedings, epidemiology statistics, and drug label data from the US and Europe. 2015-SDI-DRE-IBM-Poster See poster

Integrating the Power of Technology into Healthcare System Redesigns for Quality and Patient Care Improvement.

November 8, 2015

AUTHORS:  Lewis S. L., Whittington C., Feinman T., Battista R. CONFERENCE: AcademyHealth Concordium 2015 DATE: 2015. Implications and Actions: Users should select integrated and comprehensive software solutions with supporting services to ensure a better and more dependable experience. These technologies will elevate the future of evidence-based medicine to a level of quality and transparency often lacking […]